Company Filing History:
Years Active: 2022-2025
Title: Innovations of Mark P Davis in Drug Delivery Systems
Introduction
Mark P Davis is an accomplished inventor based in Middleton, WI (US). He has made significant contributions to the field of pharmaceutical technology, particularly in the development of drug delivery systems. With a total of three patents to his name, Davis has focused on creating innovative solutions that enhance the efficacy and safety of analgesic treatments.
Latest Patents
Davis's latest patents include "Sustained release drug delivery systems and related methods." This patent outlines methods for producing analgesia in subjects undergoing specific surgical procedures, such as arthroscopic subacromial decompression surgery. The patent details a composition that includes an active pharmaceutical agent, sucrose acetate isobutyrate, a polyorthoester, an organic solvent, and 2,6-dimethylaniline, with strict limits on the levels of impurities. Another notable patent is "Sustained release drug delivery systems with reduced impurities," which also emphasizes the importance of minimizing contaminants in drug formulations. Both patents reflect Davis's commitment to improving patient outcomes through advanced drug delivery technologies.
Career Highlights
Mark P Davis is currently associated with Durect Corporation, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in developing systems that not only deliver medications effectively but also ensure patient safety by reducing harmful impurities.
Collaborations
Davis has collaborated with notable colleagues, including Andrew R Miksztal and Judy Joice. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical technologies.
Conclusion
Mark P Davis stands out as a key figure in the field of drug delivery systems, with a focus on sustained release technologies that prioritize patient safety and efficacy. His innovative patents and collaborative efforts continue to shape the future of pharmaceutical advancements.